21 November 2017
News and Views
Links and Services
Patients who experience infusion reactions to infliximab have a high rate of therapy discontinuation, finds a study in Alimentary Pharmacology and Therapeutics.
In this study, Dr Moss and colleagues from the United States investigated the long-term ou
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors